Chapter 48 In Vivo Bioluminescence Imaging to Assess Compound Efficacy Against Trypanosoma brucei
Traditional animal models for human African trypanosomiasis rely on detecting Trypanosoma brucei brucei parasitemia in the blood. Testing the efficacy of new compounds in these models is cumbersome because it may take several months after treatment before surviving parasites become detectable in the...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Daljnji autori: | , , |
| Format: | Elektronički Poglavlje knjige |
| Jezik: | engleski |
| Izdano: |
Springer Nature
2020
|
| Teme: | |
| Online pristup: | OAPEN Library: download the publication OAPEN Library: description of the publication |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | oapen_2024_20_500_12657_47835 | ||
| 005 | 20210414 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20210414s2020 xx |||||o ||| 0|eng d | ||
| 020 | |a 978-1-0716-0294-2_48 | ||
| 020 | |a 9781071602935 | ||
| 020 | |a 9781071602966 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.1007/978-1-0716-0294-2_48 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a PS |2 bicssc | |
| 100 | 1 | |a Ritchie, Ryan |4 auth | |
| 700 | 1 | |a Barrett, Michael |4 auth | |
| 700 | 1 | |a Mottram, Jeremy |4 auth | |
| 700 | 1 | |a Myburgh, Elmarie |4 auth | |
| 245 | 1 | 0 | |a Chapter 48 In Vivo Bioluminescence Imaging to Assess Compound Efficacy Against Trypanosoma brucei |
| 260 | |b Springer Nature |c 2020 | ||
| 300 | |a 1 electronic resource (17 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Traditional animal models for human African trypanosomiasis rely on detecting Trypanosoma brucei brucei parasitemia in the blood. Testing the efficacy of new compounds in these models is cumbersome because it may take several months after treatment before surviving parasites become detectable in the blood. To expedite compound screening, we have used a Trypanosoma brucei brucei GVR35 strain expressing red-shifted firefly luciferase to monitor parasite distribution in infected mice through noninvasive wholebody bioluminescence imaging. This protocol describes the infection and in vivo bioluminescence imaging of mice to assess compound efficacy against T. brucei during the two characteristic stages of disease, the hemolymphatic phase (stage 1) and the encephalitic or central nervous system phase (stage 2). | ||
| 536 | |a Wellcome Trust | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Biology, life sciences |2 bicssc | |
| 653 | |a Firefly luciferase, Trypanosoma brucei brucei, In vivo imaging, Bioluminescence | ||
| 773 | 1 | 0 | |t Trypanosomatids |7 nnaa |o OAPEN Library UUID: 51e921c5-535d-483f-99fb-69b0c7d85e58 |
| 856 | 4 | 0 | |a www.oapen.org |u https://library.oapen.org/bitstream/id/5da4148d-721b-4444-907f-9dc0207f3744/Bookshelf_NBK558235.pdf |7 0 |z OAPEN Library: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://library.oapen.org/handle/20.500.12657/47835 |7 0 |z OAPEN Library: description of the publication |